Our mission is to improve the quality of healthcare and to fight antimicrobial resistance by bringing the cutting-edge molecular diagnostic methods to the mainstream healthcare.

We develop and provide unique and innovative microarray-based Prove-it™ technology for early and accurate diagnosis of life-threatening pathogenic microbes causing severe infections.

Our core competency is the development of reliable diagnostic assays by combining the know-how of clinical questioning and assay content design with world leading platform and software technologies. This unique approach results improved diagnostic processes and increased customer value.

Our central location within the medical campus of the University of Helsinki, as well as contacts with leading international hospitals, provide us direct everyday contacts with the customers. This enables us to design and develop assays that meet customer requirements, and validate their performance in the clinical environment.